StoneX Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
StoneX Group's ALNY Position: Q3 2026 in Review
StoneX Group opened a new position in Alnylam Pharmaceuticals (ALNY) in Q3 2026: 983 shares worth $239K. The stake represents 0.01% of the portfolio and ranks #1220 among its holdings.
730 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- StoneX Group held 983 shares of Alnylam Pharmaceuticals worth $239K as of Q3 2026.
- Alnylam Pharmaceuticals was a new StoneX Group position in Q3 2026.
- Alnylam Pharmaceuticals made up 0.01% of StoneX Group's portfolio in Q3 2026, its #1220 holding.
- 730 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.